ArticleChannels (Austin, Tex.)2019

"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".

Jaime S Horton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.